Federal initiative seeks to make access to innovative therapies wider and more financially sustainable On May 16, 2018 the US Department of Health and Human Services (HHS) published a … Read More
PPD, Evidera join NEWDIGS Initiative at MIT as a Strategic Partner
Collaboration to drive innovation across health care ecosystem WILMINGTON, N.C., May 22, 2018– Pharmaceutical Product Development, LLC (PPD), and its real-world research and market access business unit, Evidera, have joined the Massachusetts Institute … Read More
NEWDIGS in the world, May 2018
NEWDIGS leadership and thinking at recent international gatherings Gigi Hirsch and R. John Glasspool at LIGHT 2018 The second annual LIGHT Forum (Leaders in Global Healthcare and Technology) took place … Read More
NEWDIGS leaders speak at second LIGHT Forum on technology innovation in healthcare
Gigi Hirsch and R. John Glasspool join other innovation leaders to explore the challenges and potential of new technologies for patient care San Mateo, Calif., May 9, 2018 – The … Read More
Precision Financing strategies explored in FoCUS Design Lab
Healthcare innovation stakeholders co-develop solutions to make curative therapies accessible to patients, propose new pilot project CAMBRIDGE, MASSACHUSETTS—The NEWDrug Development ParadIGmS (NEWDIGS) initiative at the MIT Center for Biomedical Innovation (CBI) hosted … Read More
FoCUS Project: Recent International Event Highlights (April 2018)
NEWDIGS FoCUS project leaders have appeared in three recent meetings to share emerging perspectives on financing potentially durable but expensive new therapies. Casey Quinn and R. John Glasspool speak at … Read More
Interview with Mark Trusheim for ADAPT SMART
Road MAPPs to therapeutic innovation One of the original thought leaders of the concept of Adaptive Pathways was the NEWDIGS initiative of MIT’s Center for Biomedical Innovation. ADAPT SMART has … Read More
Massachusetts to Pioneer Next Generation Healthcare Innovation Ecosystem to Better Serve Patients
NEWDIGS Initiative at MIT leads multi-stakeholder collaboration to design and pilot a sustainable, patient-centered innovation ecosystem for a target disease CAMBRIDGE, MASSACHUSETTS, 12 DECEMBER 2017— MIT’s Center for Biomedical Innovation … Read More
MIT NEWDIGS Design Lab advances work on curative treatment financing strategies
Industry leaders, patient advocates, policymakers collaborate to make groundbreaking new therapies economically sustainable CAMBRIDGE, MASSACHUSETTS—The MIT NEW Drug Development ParadIGmS (NEWDIGS) initiative, an international biomedical innovation “think and do tank” … Read More
Gigi Hirsch and Hans-Georg Eichler featured in MGH’s Proto Magazine
Phasing Out Phase 3 What if drugs were released to the public earlier, then graded on their performance in the real world? Read the article here: http://protomag.com/articles/phasing-out-phase-3